Cargando…
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971173/ https://www.ncbi.nlm.nih.gov/pubmed/34689229 http://dx.doi.org/10.1007/s00392-021-01954-4 |
_version_ | 1784679588080648192 |
---|---|
author | Kirschbaum, Klara Vasa-Nicotera, Mariuca Zeiher, Andreas Michael Cremer, Sebastian |
author_facet | Kirschbaum, Klara Vasa-Nicotera, Mariuca Zeiher, Andreas Michael Cremer, Sebastian |
author_sort | Kirschbaum, Klara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8971173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-89711732022-04-07 SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring Kirschbaum, Klara Vasa-Nicotera, Mariuca Zeiher, Andreas Michael Cremer, Sebastian Clin Res Cardiol Letter to the Editors Springer Berlin Heidelberg 2021-10-24 2022 /pmc/articles/PMC8971173/ /pubmed/34689229 http://dx.doi.org/10.1007/s00392-021-01954-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editors Kirschbaum, Klara Vasa-Nicotera, Mariuca Zeiher, Andreas Michael Cremer, Sebastian SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
title | SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
title_full | SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
title_fullStr | SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
title_full_unstemmed | SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
title_short | SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
title_sort | sglt2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971173/ https://www.ncbi.nlm.nih.gov/pubmed/34689229 http://dx.doi.org/10.1007/s00392-021-01954-4 |
work_keys_str_mv | AT kirschbaumklara sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring AT vasanicoteramariuca sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring AT zeiherandreasmichael sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring AT cremersebastian sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring |